With a population of more than 270 million people, Indonesia is the largest country in ASEAN. The implementation of the national healthcare system (BPJS) since 2014 has created both opportunities and challenges for the pharmaceutical industry.
Our operations commenced in 2011, partnering P.T. Nicholas Laboratories and P.T. Kebayoran Pharma for our regulatory, logistics and commercial needs.
Through our representative office and collaborations above, our people provide medical promotion in Jabodetabek (Jakarta and surrounding satellite cities) and other major cities in West, Central and East Java, as well as Medan in Sumatra.